Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
about
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative DisordersThe clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosisThe utility of neuroimaging in the differential diagnosis of parkinsonian syndromesStructural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease.Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse modelA systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?Factors associated with injury in REM sleep behavior disorderThe diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.A case of REM sleep behavior disorder, narcolepsy-cataplexy, parkinsonism, and rheumatoid arthritisNeuroimaging in pre-motor Parkinson's diseasePresynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's diseaseMovement disorders: role of imaging in diagnosis.Neuroimaging: current role in detecting pre-motor Parkinson's disease.Premotor and nonmotor features of Parkinson's disease.Treatment outcomes in REM sleep behavior disorder.The PRIPS study: screening battery for subjects at risk for Parkinson's disease.Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.MDS research criteria for prodromal Parkinson's disease.Longitudinal study of cognitive function in idiopathic REM sleep behavior disorderNeurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patientsParkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trialsSurface EMG activity during REM sleep in Parkinson's disease correlates with disease severity.Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study.Decision making and executive functions in REM sleep behavior disorderPremotor Parkinson's disease: concepts and definitionsThe Role of the Serotonergic System in REM Sleep Behavior Disorder.Cognition in rapid eye movement sleep behavior disorder.Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's diseaseEnteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder.Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder.Idiopathic REM sleep behaviour disorder in the development of Parkinson's diseaseValidation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample.REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological diseaseClinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease
P2860
Q26775096-F128B215-92E9-4A9F-9533-21A136B9096BQ27004240-2E0AA267-CFEF-4AA5-9D7C-F6CD4128B4ACQ27025731-27901341-446B-4DB8-8DD5-AFF00BF5FD79Q27349459-19619C59-E329-4D29-958E-5395C373D409Q28384426-EB0D711B-D82B-482F-97AE-52DFD0A4D4C3Q30240991-1BEE86D5-C306-444E-BB62-3A601B61D899Q30454441-74394DEC-BBC7-46AC-B2B0-D7F9CD99BF1BQ30604384-08D06D3F-36CC-4846-A091-63A1FC2C5FCEQ30635471-9BD560C4-8117-423B-9487-D4C9814C0C7DQ30841744-2F8603C4-DC14-49B0-8C8E-BAA6D1F5FDF1Q33552537-393CFDE1-67E4-4DE0-8877-FD94AF82DCECQ33676222-DC67F9B0-EF2A-4D01-85C8-287FFE22D9E8Q33731267-05F25B50-1A2A-487A-B950-008A9FA87D28Q34066195-F5F364ED-B27C-4157-9ED4-6E9F0ADF83E7Q34136898-AF973CB7-C881-48CB-8FAB-51ABC1711D47Q34234625-21D618EE-3C82-4DF5-A367-26BC6149B22EQ34274224-F76CC802-AFE6-4588-B8D4-9FA6EE10AE8AQ34324499-2F50AD18-73B6-47EB-9C18-273913E57865Q34361343-D27C4704-9BC0-4694-8A89-D4B0159B0547Q34372099-5A04597E-2733-4473-B45E-55CD8BFA433DQ34463276-A359C9C8-C668-42E3-BED0-502007BF43F6Q34498279-1636F926-8EDF-48AD-850C-64EEBCDA00F7Q34821463-36E6A062-E7E0-4550-A6DC-BBF154D214E2Q35107980-C31B9833-E184-4EEC-8B0A-6855C5FE1F68Q35211066-74D84EEB-D9C3-4D82-990E-221A372DD825Q35532154-54C67564-8E19-40D8-98CD-58A186E3D57AQ35726695-2F3E4714-71CA-4643-A054-14423B59C473Q35875634-52CE557E-F0C7-472A-ADF4-925197609FCAQ35910731-0ECB2D6B-B92A-4B38-B9FC-566C05922CA0Q35936402-144E6B61-114F-4DAA-BA29-0D3F8538F4CEQ35966121-45E40806-0B2E-421E-828A-CEFD814269B8Q36135045-E70FF275-7048-4A9F-B5CC-FF2FFE1F3395Q36270657-3BB47F22-7463-47E5-803F-448A569FD1F4Q36300054-45D144BA-0ECB-494C-8688-0184514038B2Q36626762-52EB18DF-AF58-427C-B14F-35240EF79CD8Q36656691-EC998762-E19F-400C-8816-C490F56724E3Q36774991-462102A7-E184-4B0A-9668-F3E0A8D6D15FQ36851239-34C358F9-17CB-460E-9D2B-4411C053EBB5Q37100913-8F89C818-E710-4A6C-A7E8-003B271BF6DEQ37121555-90848652-3924-410C-903A-D2BF56D26618
P2860
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Decreased striatal dopamine tr ...... prospective study [corrected].
@en
Decreased striatal dopamine tr ...... prospective study [corrected].
@nl
type
label
Decreased striatal dopamine tr ...... prospective study [corrected].
@en
Decreased striatal dopamine tr ...... prospective study [corrected].
@nl
prefLabel
Decreased striatal dopamine tr ...... prospective study [corrected].
@en
Decreased striatal dopamine tr ...... prospective study [corrected].
@nl
P2093
P50
P921
P1433
P1476
Decreased striatal dopamine tr ...... prospective study [corrected].
@en
P2093
Alex Iranzo
Eduard Tolosa
Francisco Lomeña
Heike Stockner
Isabel Vilaseca
Javier Pavía
Joan Santamaria
Judith Gallego
Manel Salamero
P304
P356
10.1016/S1474-4422(10)70216-7
P577
2010-09-16T00:00:00Z